Table Of Content

PROSTAGLANDINS & other LIPID MEDIATORS Prostaglandins & other Lipid Mediators 58 ( 1999) 29 AUTHOR INDEX Akmal, Y., Itabash, Y., Pataricza, J., 103 Amemiya, ° Janowiak, M.A., 207 Pérez-Alvarez, M.J., 19 Austin, S.C. Kanno, K., 187 Prokopowicz, D., 159 Beharry, K.., Kim, L.M., 113 Randel, R.D., 125 Bernhard, M.., Kis, B., 103 Samejima, Y. Bridges, P.J., | Kobayashi, I 149 167 Koseki, Y. Calcerrada, M.C. LeaMaster @arra,G., 9 149, 167 Seleznev, K.G. Catalan, R.E., 19 Lee, C.-M. Shyue, S.-K., 87 Chang, W.-C., 65 Lemme, C. Stahringer, R.C., 125 Chen, B.-C., 87 Lin, W.-W. Suzuki, H., Chen, C.-J., 65 bia. 239 Suzuki, K. Dansco, G., 103 Martinez, A.M Tachibana, Doria, D., 9 Masuyama, K., 2 T akeda, N., Pa Eura, M., 29 Matsuda, T. alamini A Federico, C., 273 Matsumura, E. I aim ai, M. Flisiak, R., 159 McGift, J.G., 6 [ elegdy Franco, L., 9 Mezei, Z., 103 I itova, E.A., | Fujimura, M., 219 Mizugaki, M., 17 Tumbaga, P., 2 Fukui, H., 29 253, 263 Uzuki, M., 179 Funk, C.D., 225 1 Modanlou, H.D Vagnoni, K.E., 207 Gecse, A., 103 Murai, Y., 25 Vincent, D.L., 77, 11 Hirose, Y., 18“S7 Myou, S., 219 149° 167 Hishinuma, T., 179, 187, Nakahata, N., 51 Weems, C.W., 7 5 53, 263 Nakamura, H., 179, 187 139, 149, 167 Hoch, B., 285 Nakasaki, T., 29 Weems, Y.S., 77 Holyoak, G.R. Neuendorff, D.A., 125 149. 167 Honma, S., 51 Nikonov, G.L, | Wiercinska-Drapalo, A. Hsu, Y.-W., 87 Nishimaki, S., 43 Yamaguchi, H., 187 Huang, H.-S., 65 Nobata, K., 219 Yamamoto, S., 65 Ikeda, S., 51 Ogino, S., 29 Yamanobe, S., 253 Ishikawa, T., 29 Ohizumi, Y., Yamazaki, T., 253, 263 Ishiura, Y., 219 Papp, J.G., Yumoto, E., 29 PII: $0090-6980(99)00052-0 PROSTAGLANDINS & other ar LIPID MEDIATORS ELSEVIER Prostaglandins & other Lipid Me SUBJECT INDEX Abortion, 7 spectrometry (GC MS Phospholipase C, 51 Adenylate cyclase- 179, 187 Phospholipid activating polypeptide, GC/MS, 253, 263 hydroperoxide 103 Glial cells, 5] glutathione peroxidase Airway eosinophil G 5] 65 accumulation, 219 Guinea pigs, 219 Piglets, 273 Allergic 9 Pituitary, 103 Helix obac te I Ps lor I bronchoconstriction, fL1i1rruad o mmoeadraliicriinna lls; l Placenta, 77, 139 219 Histamine H1 receptor, Plasma salicylate, 125 Apnea, 285 9 Platelet aggregation, 103 Arachidonic acid, Human blood, 187 Platelets, 103 Aspirin, 125 Hy per-responsiveness of Polymyxin-B, 219 Bowel, 159 nasal mucosa, 29 Postpartum, 125 Brahman cows, 125 Immunoblotting, Preeclampsia, 43 Brain sparing effect, - Indomethacin, 11 Pregnancy, 77 cAMP, 87 Inflammation, 159 67 Cerebral blood flow Joint fluid, 179 Pregnancy specific protein Cerebral cortex, 19 Leech, l B, Cortisol, 77 Leukotriene, 23] Pregnancy-specific protein Cyclooxygenase, 9, 65, Lipopolysaccharide, 207 B, 139 103, 231.273 Lipoxygenase, 65, 231 Pregnant sheep Cyclooxygenase-2, 207 LPS, 87 Preterm, 285 Diabetes mellitus, 263 Morphine sulfate, 273 > Progesterone, 113, 139 6,15-diketo-13,14-dihydro- Murine macrophage, 87 149 prostaglandin F,, 187 Neonate, 43 Propranolol-induced 2,3-dinor-6-keto-PGF,,, Newborn, 273 bronchoconstriction 285 Nitric oxide, 9, 8 7 ) 19 2,3-dinor-TxB, 285 Ovine, 207 Prostacyclin, 1, 43, 187 Eicosanoid, 231 PACAP, 103 207, 253, 263 Eicosanoids, 103 PAF, 19 29 Prostaglandin, 159, 179, Endoscopy, 159 Parity, 125 187, 231, 253, 3, 263 Estradiol-178, 77, 113, PGE, 139, 149 1 Prostaglandin E, 9, 87 139, 149, 167 PGE, 159, 179 Prostaglandin F,, 125 Estrous cycle, 207 PGF,,, 77, 113, Prostanoids, 27723 Gas chromatography/mass 167 Protein kinase C, 19 PII: $0090-6980(99)00053-2 294 Subject Index / Prostaglandins & other Lipid Mediators 58 (1999) 293-294 Rat, 29 Rheumatoid arthritis, 179 Thromboxane, 43, 253, Ratio, 285 Sheep, 77, 139, 149, 167 263 Rat platelet, 103> 12(S)- Trilostane, 77, 149 Reproduction, 12: hydroxyeicosatetraenoic TXA, receptor mRNA, Retinal vascular acid, 65 a occlusion, 253 Tamoxiten, 113, 167 Ulcerative colitis, 159 Sines ers